Please assess the completion status of the following clinical trial:

Trial Title: The Study Of Fluconazole For Vulvovaginal Candidiasis

Study Design Characteristics:
- Allocation: None
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with clinical symptoms and signs of vulvovaginal candidiasis.~* Patients tested positive for Candida by fungal culture.~* Patients who can agree not to have intercourse up to 28 days after dosing.~Exclusion Criteria:~* Patients with a history of hypersensitivity to fluconazole.~* Patients with severe renal dysfunction.~* Patients with liver disorder.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Fluconazole (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).